Improvement of Artificial Endocrine Pancreas (Biostator; GCIIS) Performance Combining Feedback Controlled Insulin Administration with a Pre-Programmed Insulin Infusion

Summary It is well known that the glycemic control accomplished by the artificial endocrine pancreas (Biostator; GCIIS), requires an excessive insulin consumption. In order to improve the Biostator performance, we have studied 5 insulin dependent diabetic patients on anticipated automatic pre-programmed insulin infusion starting at the beginning of breakfast. Such an operating method allowed us to obtain a significant reduction in insulin requirements (from 17,3 ± 2,2 U to 13,3 ± 2,2 U), and a better glycemic control (MBG 98,7 ± 5,4 vs 111,1 ± 5,6; M 2,34 ± 0,9 vs 6,96 ± 1,7; Δ G 43,8 ± 3 vs 73,4 ± 9,7), as compared to those observed under conventional feed-back control in relation to breakfast.